multi-VEGF/PDGF DARPins (Molecular Partners/Allergan)

N/A

Report date: 2025/03/20 15:02:13

Base Information

Drug Namemulti-VEGF/PDGF DARPins (Molecular Partners/Allergan)
Drug Alias Namemulti-VEGF/PDGF DARPins (Molecular Partners/AbbVie)DARPins (Molecular Partners/Actavis)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWet age-related macular degenerationEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesAllergan PlcAllergan Inc
Active IndicationsWet age-related macular degeneration
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A